Association between plasma phospholipid saturated fatty acids and metabolic markers of lipid, hepatic, inflammation and glycaemic pathways in eight European countries: a cross-sectional analysis in the EPIC-InterAct study.
Ju-Sheng ZhengStephen J SharpFumiaki ImamuraAlbert KoulmanMatthias B SchulzeZheng YeJules GriffinMarcela GuevaraJosé María HuertaJanine KrögerIvonne SluijsAntonio AgudoAurelio BarricarteHeiner BoeingSandra Colorado-YoharCourtney DowMiren DorronsoroPia T DinesenGuy FagherazziPaul W FranksEdith J M FeskensTilman KühnVerena Andrea KatzkeTimothy J KeyKay-Tee KhawMaria Santucci de MagistrisFrancesca Romana ManciniElena Molina-PortilloPeter M NilssonAnja OlsenKim OvervadDomenico PalliJose Ramón QuirósOlov RolandssonFulvio RicceriAnnemieke M W SpijkermanNadia SlimaniGiovanna TagliabueAnne TjonnelandRosario TuminoYvonne T van der SchouwClaudia LangenbergElio RiboliNita G ForouhiNicholas J WarehamPublished in: BMC medicine (2017)
Subtypes of SFAs are associated in a differential way with metabolic markers of lipid metabolism, liver function and chronic inflammation, suggesting that odd-chain SFAs are associated with lower metabolic risk and even-chain SFAs with adverse metabolic risk, whereas mixed findings were obtained for very-long-chain SFAs. The clinical and biochemical implications of these findings may vary by adiposity and alcohol intake.